Table 1.
Correlation between expression of lncRNA XIST and clinic pathological features in cervical cancer patients (n = 30)
| Parameters | Group | Total | lncRNA XIST# | P | |
|---|---|---|---|---|---|
| High | Low | ||||
| Age | ≤ 60 | 22 | 11 | 11 | 0.544 |
| > 60 | 8 | 3 | 5 | ||
| Tumor size | ≤ 5 cm | 22 | 16 | 6 | 0.034* |
| > 5 cm | 8 | 2 | 6 | ||
| Figo stage | I | 15 | 4 | 11 | 0.033* |
| II | 7 | 6 | 1 | ||
| III | 4 | 3 | 1 | ||
| IV | 4 | 1 | 3 | ||
| Tumor differentiation | Well | 7 | 6 | 1 | 0.027* |
| Moderate | 5 | 3 | 2 | ||
| Poor | 18 | 5 | 13 | ||
| Pathological type | Squamous | 14 | 8 | 6 | 0.746 |
| Adenocarcinoma | 16 | 6 | 10 | ||
| Lymphatic metastasis | Yes | 20 | 12 | 8 | 0.038* |
| No | 10 | 2 | 8 | ||
#Low and high expression group were divided according to the median ratio of relative lncRNA XIST expression
* P value was determined by chi-square analysis. P < 0.05 was considered statistically significant